BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 54941)

  • 1. Chemotherapy of breast cancer treatment of metastatic, recurrent or inoperable breast cancer.
    Falkson G; Falkson HC
    S Afr J Surg; 1975 Sep; 13(3):121-7. PubMed ID: 54941
    [No Abstract]   [Full Text] [Related]  

  • 2. [Local radiotherapy and adriblastin chemotherapy in metastatic breast carcinoma].
    Renner H; Zeinz M
    Strahlentherapie Sonderb; 1978; 75():199-201. PubMed ID: 95495
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical management of metastatic breast cancer.
    Lawrence W; Brown PW; Terz JJ
    Surgery; 1977 Aug; 82(2):173-81. PubMed ID: 69328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy in the treatment of advanced breast cancer.
    Russell IS; Moon WJ
    Med J Aust; 1977 Aug; 2(9):294-6. PubMed ID: 72343
    [No Abstract]   [Full Text] [Related]  

  • 5. [Survival kinetics of breast cancer patients undergoing combined chemotherapy for recurrences and metastases].
    Korman DB; Maslova IA; Borisov AI
    Vopr Onkol; 1982; 28(8):14-9. PubMed ID: 7113064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of chemotherapy in metastatic breast cancer.
    Garber JE; Henderson IC
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):807-21. PubMed ID: 2481671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of recurrent breast cancer.
    Robert NJ; Beveridge RA
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):709-19. PubMed ID: 7731643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The principle of chemotherapy in relapse and metastatic breast cancer].
    Breast Cancer Society Chinese Anti-Cancer Association
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(2):73-5. PubMed ID: 21418985
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combination therapy of local tumour recurrence in patients with breast cancer (author's transl)].
    Szepesi T; Sabitzer H; Sabitzer G
    Wien Klin Wochenschr; 1979 Jan; 91(1):15-8. PubMed ID: 425521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of estrogen receptor status on response to combination chemotherapy for recurrent breast cancer.
    Mortimer J; Reimer R; Greenstreet R; Groppe C; Bukowski R
    Cancer Treat Rep; 1981; 65(9-10):763-6. PubMed ID: 7273011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of drug-resistant metastasizing cancer of the breast with an antiestrogen].
    Frederiksen PL; Engelholm A; Mouridsen HT
    Ugeskr Laeger; 1978 Oct; 140(43):2639-41. PubMed ID: 360540
    [No Abstract]   [Full Text] [Related]  

  • 12. Palliative chemotherapy for recurrent and metastatic esophageal cancer.
    Grünberger B; Raderer M; Schmidinger M; Hejna M
    Anticancer Res; 2007; 27(4C):2705-14. PubMed ID: 17695436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytostatic therapy in metastasizing breast cancer].
    Gynning I; Mattsson W
    Lakartidningen; 1978 Apr; 75(15):1512-5. PubMed ID: 651418
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvant chemotherapy in cancer.
    Block JB; Isacoff WH
    Semin Oncol; 1977 Mar; 4(1):109-15. PubMed ID: 265100
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy of breast cancers].
    Brule G
    Arq Patol; 1974; 46(2-3):267-72. PubMed ID: 4458639
    [No Abstract]   [Full Text] [Related]  

  • 16. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
    Abe O; Izuo M; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
    Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of breast cancer. Standard treatment.
    Duffey PH
    Ariz Med; 1974 Mar; 31(3):197. PubMed ID: 4131961
    [No Abstract]   [Full Text] [Related]  

  • 18. Superiority of letrozole over tamoxifen in the first-line treatment of metastatic breast cancer patients with normal serum Her-2/neu levels: question of tamoxifen resistance.
    Altundag K; Altundag O
    J Clin Oncol; 2003 Dec; 21(24):4656; author reply 4657. PubMed ID: 14673060
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cytostatic drug combinations in the treatment of metastatic cancer of the breast].
    Svennevig JL; Wennberg JE; Bernstein O; Lange J
    Tidsskr Nor Laegeforen; 1975 Nov; 95(32):1854-5, 1866. PubMed ID: 1198566
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prognostic factors in the drug therapy of metastasizing breast cancer].
    Mörz R; Schemper M; Bettelheim P; Breyer S; Francesconi M; Graninger W; Jakesz R; Kolb R; Micksche M; Rainer H; Reiner G; Moser K
    Acta Med Austriaca Suppl; 1979; 6():319-22. PubMed ID: 299219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.